Research location

Vernon Hills

Illinois, United States

Published trials52
Site observations52
Linked trials published52
Page1 / 2
Advertisement

Research activity in Vernon Hills

Illinois, United States

CureCurrent currently publishes aggregate city-level research activity for this location: 52 trials and 52 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Vernon Hills

52 linked trials · page 1 of 2
A Study to Investigate the Safety and Efficacy of ABBV-105 Alone or in Combination With Upadacitinib (ABBV-599 Combination) in Participants With Active Rheumatoid ArthritisNCT03682705 · 2018-10-08 · 1 site observation
COMPLETED
A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) With an Inadequate Response or Intolerance to Biologic DMARDsNCT02706847 · 2016-03-15 · 1 site observation
COMPLETED
A Study to Compare Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have Not Previously Taken MethotrexateNCT02706873 · 2016-02-23 · 1 site observation
COMPLETED
A Study Comparing Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on a Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response to csDMARDs AloneNCT02675426 · 2015-12-17 · 1 site observation
COMPLETED
An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With MethotrexateNCT02187055 · 2014-08-01 · 1 site observation
COMPLETED
A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background MethotrexateNCT02147587 · 2014-06-01 · 1 site observation
COMPLETED
A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 StudyNCT02158546 · 2014-05-01 · 1 site observation
COMPLETED
An Extension Study in Participants With Moderate to Severe Rheumatoid ArthritisNCT01885078 · 2013-06-27 · 1 site observation
COMPLETED
A Study in Moderate to Severe Rheumatoid Arthritis ParticipantsNCT01721057 · 2012-12-01 · 1 site observation
COMPLETED
A Study in Participants With Moderate to Severe Rheumatoid ArthritisNCT01711359 · 2012-11-01 · 1 site observation
COMPLETED
A Study to Evaluate the Long-term Safety and Efficacy of ASP015K in Subjects Previously Enrolled in a Phase 2 ASP015K Rheumatoid Arthritis StudyNCT01711814 · 2012-09-26 · 1 site observation
COMPLETED
A Long-Term Extension Study of WA22762 and NA25220 of Subcutaneous (SC) Tocilizumab (TCZ) in Moderate to Severe Rheumatoid Arthritis (RA)NCT01662063 · 2012-08-01 · 1 site observation
COMPLETED
A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who Have Had an Inadequate Response to MethotrexateNCT01554696 · 2012-07-06 · 1 site observation
COMPLETED
Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 DiabetesNCT01606007 · 2012-07-01 · 1 site observation
COMPLETED
A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid ArthritisNCT01565655 · 2012-06-19 · 1 site observation
COMPLETED
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep ApnoeaNCT01557166 · 2012-06-07 · 1 site observation
COMPLETED
SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension StudyNCT01436175 · 2012-02-27 · 1 site observation
TERMINATED
A Study To Assess the Immune Response Following Administration Of Influenza and Pneumococcal Vaccines To Subjects With Rheumatoid Arthritis Receiving CP-690,550 Or PlaceboNCT01359150 · 2011-09-01 · 1 site observation
COMPLETED
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive DisorderNCT01435759 · 2011-05-31 · 1 site observation
COMPLETED
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid ArthritisNCT01232569 · 2011-03-01 · 1 site observation
COMPLETED
Safety and Efficacy of RX-10100 to Treat Major Depressive DisorderNCT01273376 · 2010-12-01 · 1 site observation
COMPLETED
A Study of the Effects of RoActemra/Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Methotrexate (VISARA)NCT01163747 · 2010-09-01 · 1 site observation
COMPLETED
A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid ArthritisNCT01007435 · 2009-10-31 · 1 site observation
COMPLETED
CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus GlimepirideNCT00968812 · 2009-09-01 · 1 site observation
COMPLETED
A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis MedicationsNCT00856544 · 2009-05-01 · 1 site observation
COMPLETED
A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs)NCT00891020 · 2009-05-01 · 1 site observation
COMPLETED
Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 DiabetesNCT00859898 · 2009-04-01 · 1 site observation
COMPLETED
Prevalence of Chronic Airway Obstruction in Subjects With a History of Cigarette Smoking in a Primary Care SettingNCT01013948 · 2009-02-01 · 1 site observation
COMPLETED
Open Label Extension for Patients Coming From the Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA)NCT00753454 · 2008-09-01 · 1 site observation
COMPLETED
An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release TabletsNCT00643851 · 2008-06-01 · 1 site observation
COMPLETED
An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.NCT00696436 · 2008-04-01 · 1 site observation
COMPLETED
Dosing Flexibility Study in Patients With Rheumatoid ArthritisNCT00580840 · 2007-12-01 · 1 site observation
COMPLETED
A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid ArthritisNCT00535782 · 2007-10-31 · 1 site observation
COMPLETED
Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and DepressionNCT00518986 · 2007-10-01 · 1 site observation
COMPLETED
Airway Limitation Study: Study In Primary Care Centers Of Chronic Bronchitis In Long-Term Cigarette Smokers Of At Least 40 Years Of Age With Symptoms Of Cough And Shortness Of BreathNCT00442468 · 2007-04-01 · 1 site observation
COMPLETED
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid ArthritisNCT00413699 · 2007-02-05 · 1 site observation
COMPLETED
Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 DiabetesNCT00399711 · 2006-11-01 · 1 site observation
COMPLETED
A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast CancerNCT00373256 · 2006-11-01 · 1 site observation
COMPLETED
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or NaproxenNCT00346216 · 2006-10-04 · 1 site observation
COMPLETED
A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseNCT00327015 · 2006-05-01 · 1 site observation
COMPLETED
COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With HypertensionNCT00273052 · 2006-01-05 · 1 site observation
COMPLETED
An Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients Completing Treatment in Tocilizumab Core StudiesNCT00720798 · 2005-09-01 · 1 site observation
COMPLETED
Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin AloneNCT00121667 · 2005-08-01 · 1 site observation
COMPLETED
Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseNCT00121641 · 2005-07-01 · 1 site observation
COMPLETED
Safety of Inhaled Insulin With Type 1 and Type 2 DiabetesNCT00308737 · 2005-06-01 · 1 site observation
COMPLETED
A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid ArthritisNCT00106574 · 2005-04-01 · 1 site observation
COMPLETED
Efficacy Study of MM-093 in Rheumatoid Arthritis Patients on Methotrexate (MTX)NCT00105976 · 2005-02-01 · 1 site observation
COMPLETED
The CLEVER Study - Coreg And Left Ventricular Mass RegressionNCT00108082 · 2005-01-01 · 1 site observation
COMPLETED
Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe HypertensionNCT00095394 · 2004-09-01 · 1 site observation
COMPLETED
Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On InsulinNCT00329225 · 2002-09-01 · 1 site observation
COMPLETED
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.